158 related articles for article (PubMed ID: 15255431)
21. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
Mojzes J; Battyáni Z; Grexa E
Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
[TBL] [Abstract][Full Text] [Related]
22. Livedo Reticularis: An Enigma.
Sangle SR; D'Cruz DP
Isr Med Assoc J; 2015 Feb; 17(2):104-7. PubMed ID: 26223086
[TBL] [Abstract][Full Text] [Related]
23. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
24. [Livedo reticularis in patients with systemic lupus erythematosis and its association with anticardiolipin antibodies].
Ostos Z; Chacón-Petrola Mde L; Flores-Ch ME; Torres A; Herrera A; Blanck E; Espig H
Invest Clin; 2002 Mar; 43(1):15-24. PubMed ID: 11921743
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis.
Serra CR; Rodrigues SH; Silva NP; Sztajnbok FR; Andrade LE
Clin Exp Rheumatol; 1999; 17(3):375-80. PubMed ID: 10410276
[TBL] [Abstract][Full Text] [Related]
26. Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency.
Nakayama T; Yamamoto T; Kanmatsuse K; Kokubun S
Rheumatol Int; 2003 Jul; 23(4):198-200. PubMed ID: 12856147
[TBL] [Abstract][Full Text] [Related]
27. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
28. Cryofibrinogenemia with polyarthralgia, Raynaud's phenomenon and acral ulcer in a patient with Graves' disease treated with methimazole.
Hosoi K; Makino S; Yamano Y; Sasaki M; Takeuchi T; Sakane S; Ohsawa N
Intern Med; 1997 Jun; 36(6):439-42. PubMed ID: 9213194
[TBL] [Abstract][Full Text] [Related]
29. Livedo reticularis.
Picascia DD; Pellegrini JR
Cutis; 1987 May; 39(5):429-32. PubMed ID: 3581915
[TBL] [Abstract][Full Text] [Related]
30. Livedo reticularis: an underutilized diagnostic clue in cholesterol embolization syndrome.
Chaudhary K; Wall BM; Rasberry RD
Am J Med Sci; 2001 May; 321(5):348-51. PubMed ID: 11370799
[TBL] [Abstract][Full Text] [Related]
31. [A case of Sneddon syndrome].
Shimizu K; Numaga J; Takahashi M; Matsunaga T
Nippon Ganka Gakkai Zasshi; 1995 Jan; 99(1):104-8. PubMed ID: 7887321
[TBL] [Abstract][Full Text] [Related]
32. Thyrotoxicosis due to the simultaneous occurrence of silent thyroiditis and Graves' disease.
Ho SC; Eng PH; Fok AC; Ng DC; Khoo DH
Thyroid; 1999 Nov; 9(11):1127-32. PubMed ID: 10595464
[TBL] [Abstract][Full Text] [Related]
33. [2 cases of Sneddon syndrome].
Florczak E; Dobrogowska-Kunicka J; Paschalis-Purtak K; Puciłowska B
Pol Arch Med Wewn; 1992 Jun; 87(6):393-8. PubMed ID: 1408998
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
36. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
Hoang TD; Mai VQ; Clyde PW; Shakir MK
Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
[TBL] [Abstract][Full Text] [Related]
38. Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole.
Huang CN; Hsu TC; Chou HH; Tsay GJ
Lupus; 2004; 13(6):450-4. PubMed ID: 15303572
[TBL] [Abstract][Full Text] [Related]
39. Graves' disease presenting with severe cholestasis.
Regelmann MO; Miloh T; Arnon R; Morotti R; Kerkar N; Rapaport R
Thyroid; 2012 Apr; 22(4):437-9. PubMed ID: 22458973
[TBL] [Abstract][Full Text] [Related]
40. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
